Xbiotech logo

Xbiotech share price today

(XBIT)

Xbiotech share price is $4.48 & ₹384.43 as on 7 Jan 2025, 2.30 'hrs' IST

$4.48

0.06

(1.36%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Xbiotech share price in Dollar and Rupees. Guide to invest in Xbiotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xbiotech, along with analyst recommendations, forecasts, and comprehensive financials.

Xbiotech share price movements

  • Today's Low: $4.47
    Today's High: $4.67

    Day's Volatility :4.28%

  • 52 Weeks Low: $3.51
    52 Weeks High: $9.96

    52 Weeks Volatility :64.76%

Xbiotech Returns

PeriodXbiotech IncSector (Health Care)Index (Russel 2000)
3 Months
-35.76%
-8.4%
0.0%
6 Months
-25.59%
-3.8%
0.0%
1 Year
9.14%
-0.1%
0.0%
3 Years
-61.73%
2.9%
-19.8%

Xbiotech Key Statistics

in dollars & INR

Previous Close
$4.42
Open
$4.52
Today's High
$4.67
Today's Low
$4.47
Market Capitalization
$120.4M
Today's Volume
$64.9K
52 Week High
$9.96
52 Week Low
$3.51
Revenue TTM
$300.0K
EBITDA
$-40.6M
Earnings Per Share (EPS)
$-1.08
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-15.75%

How to invest in Xbiotech from India?

It is very easy for Indian residents to invest directly in Xbiotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xbiotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xbiotech or XBIT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xbiotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xbiotech shares which would translate to 0.192 fractional shares of Xbiotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xbiotech, in just a few clicks!

Returns in Xbiotech for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xbiotech investment value today

Current value as on today

₹1,13,840

Returns

₹13,840

(+13.84%)

Returns from Xbiotech Stock

₹10,617 (+10.62%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Xbiotech

46%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Xbiotech on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 46% more investors are searching Xbiotech in the last 30 days versus the previous period.

Global Institutional Holdings in Xbiotech

  • BlackRock Inc

    3.72%

  • Vanguard Group Inc

    3.48%

  • Geode Capital Management, LLC

    1.48%

  • Millennium Management LLC

    0.92%

  • UBS Asset Mgmt Americas Inc

    0.83%

  • State Street Corp

    0.74%

Analyst Recommendation on Xbiotech

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Xbiotech(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Xbiotech

What analysts predicted

Upside of 301.79%

Current:

$4.48

Target:

$18.00

Insights on Xbiotech

  • Price Movement

    In the last 1 month, XBIT stock has moved down by -30.9%
  • Increasing Revenue

    Revenue is up for the last 3 quarters, 300.0K → 2.62M (in $), with an average increase of 44.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -13.00M → -5.01M (in $), with an average increase of 159.3% per quarter
  • XBIT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 14.0%
  • XBIT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 116.2%
  • Price to Sales

    ForXBIT every $1 of sales, investors are willing to pay $442.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Xbiotech Technicals Summary

Sell

Neutral

Buy

Xbiotech is currently in a neutral trading position according to technical analysis indicators.

Xbiotech Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Xbiotech Inc
-32.62%
-25.59%
9.14%
-61.73%
-75.81%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Xbiotech Inc
NA
NA
0.0
0.0
-0.16
-0.12
NA
6.31
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Xbiotech Inc
Buy
$120.4M
-75.81%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Xbiotech

xbiotech is developing a first-in-class monoclonal antibody (mabp1) to inhibit chronic inflammation. chronic (sterile) inflammatory responses are involved in the progression of many serious and common diseases. mabp1 is being investigated in many important areas of medicine, including: cancer, leukemia (phase 1); type 2 diabetes (phase2); psoriasis (phase 2); and vascular disease (phase 2). mabp1 is a true human™ antibody cloned from a natural human immune response and—unlike currently marketed antibodies—it has not undergone any modification to alter its function. it has exhibited the best potential tolerability and safety during the clinical trials. xbiotech has established a current good manufacturing practices (cgmp) program to commercialize its lead product candidate. the company has purchased land and designed a commercial-scale plant with 25,000l total bioreactor capacity. construction of the facility is planned to commence in 4th quarter 2011..
Organization
Xbiotech
Employees
82
CEO
Mr. John Simard
Industry
Health Technology

Management People of Xbiotech

NameTitle
Mr. John Simard
Founder, President, CEO & Chairman
Ms. Angela Hu
Director of Finance
Dr. Sushma Shivaswamy Ph.D.
Chief Scientific Officer

Important FAQs about investing in Xbiotech from India :

What is Xbiotech share price today?

Xbiotech share price today stands at $4.48, Open: $4.52 ; Previous Close: $4.42 ; High: $4.67 ; Low: $4.47 ; 52 Week High: $9.96 ; 52 Week Low: $3.51. The stock opens at $4.52, after a previous close of $4.42. The stock reached a daily high of $4.67 and a low of $4.47, with a 52-week high of $9.96 and a 52-week low of $3.51.

Can Indians buy Xbiotech shares?

Yes, Indians can invest in the Xbiotech (XBIT) from India.

With INDmoney, you can buy Xbiotech at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xbiotech at zero transaction cost.

How can I buy Xbiotech shares from India?

It is very easy to buy Xbiotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xbiotech be purchased?

Yes, you can buy fractional shares of Xbiotech with INDmoney app.

What are the documents required to start investing in Xbiotech stocks?

To start investing in Xbiotech, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xbiotech

Today’s highest price of Xbiotech (XBIT) is $4.67.

Today’s lowest price of Xbiotech (XBIT) is $4.47.

What is today's market capitalisation of Xbiotech

Today's market capitalisation of Xbiotech XBIT is 120.4M

What is the 52 Week High and Low Range of Xbiotech

  • 52 Week High

    $9.96

  • 52 Week Low

    $3.51

What are the historical returns of Xbiotech?

  • 1 Month Returns

    -32.62%

  • 3 Months Returns

    -25.59%

  • 1 Year Returns

    9.14%

  • 5 Years Returns

    -75.81%

Who is the Chief Executive Officer (CEO) of Xbiotech

Mr. John Simard is the current Chief Executive Officer (CEO) of Xbiotech.